Comparison

Fluzoparib European Partner

Item no. TMO-T8806-5mg
Manufacturer TargetMol
CASRN 1358715-18-0
Amount 5 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 1 mg 25 mg 2 mg 500 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 99.38%
Citations Wang L , Yang C , Xie C , et al. Pharmacologic characterization of fluzoparib, a novel poly(ADP?ribose) polymerase inhibitor undergoing clinical trials[J]. Cancer Science, 2019.
Smiles Fc1ccc(Cc2n[nH]c(=O)c3ccccc23)cc1C(=O)N1CCn2nc(nc2C1)C(F)(F)F
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias HS10160,SHR3162
Shipping Condition Cool pack
Available
Manufacturer - Targets
PARP
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
472.4
Description
Fluzoparib (SHR3162) is a novel, potent, and orally available inhibitor of PARP, potentially for the treatment of solid tumours.
Pathways
Chromatin/Epigenetic|||DNA Damage/DNA Repair

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close